2025 NURS 6630 Final Exam Prep Test With 76 Correctly Answered Questions And Correct Answers// Nurs 6630 Psychopharmacology Final Exam Prep

2025 NURS 6630 Final Exam
Prep Test With 76 Correctly
Answered Questions And
Correct Answers// Nurs
6630 Psychopharmacology
Final Exam Prep 2025-2026
Nurs 6630 Final Exam

, lOMoAR cPSD| 21953575




NURS 6630 FINAL EXAM

QUESTION 1
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs

tomanage the top-down cortical control and the excessive drive from striatal hyperactivity?


A. Stimulants B. Antidepressants C. Antipsychotics D. SSRIs


QUESTION 2


The PMHNP is selecting a medication treatment option for a patient who is exhibiting

psychotic behaviors with poor impulse control and aggression. Of the available treatments,

which can help temper some of the adverse effects or symptoms that are normally caused

by D2 antagonism?


A. First-generation, conventional antipsychotics B. First-generation, atypical antipsychotics

C. Second-generation, conventional antipsychotics D. Second-generation, atypical

antipsychotics


QUESTION 3


The PMHNP is discussing dopamine D2 receptor occupancy and its association with

aggressive behaviors in patients with the student. Why does the PMHNP prescribe a

standard dose of atypical antipsychotics?


A. The doses are based on achieving 100% D2 receptor occupancy. B. The doses are based

on achieving a minimum of 80% D2 receptor occupancy. C. The doses are based on

achieving 60% D2 receptor occupancy. D. None of the above.




pg. 1

, lOMoAR cPSD| 21953575




QUESTION 4


Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the

patient with psychosis and aggression?


A. There is too high a risk of serious adverse side effects. B. It can exaggerate the

psychotic symptoms. C. Clozapine (Clozaril) should not be used as high-dose monotherapy.

D. There is no documentation that clozapine (Clozaril) is effective for patients who are

violent.


QUESTION 5


The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the

PMHNP exhibits proper care for this patient?


A. Explaining to the patient that there are no risks of EPS B. Prescribing the patient 12
mg/dail

C. Titrating the dose by increasing it every 5–7 days D. Writing a prescription for a

higher dose of oral risperidone (Risperdal) to achieve high D2 receptor occupancy


QUESTION 6


The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and

impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood

stabilizer willthe PMHNP select? A. Lithium (Lithane) B. Phenytoin (Dilantin) C. Valproate

(Depakote) D. Topiramate (Topamax)




pg. 2

, lOMoAR cPSD| 21953575




QUESTION 7


The parents of a 7-year-old patient with ADHD are concerned about the effects of

stimulants on their child. The parents prefer to start pharmacological treatment with a

non-stimulant. Which medication will the PMHNP will most likely prescribe?


A. Strattera B. Concerta C. Daytrana D.


AdderallQUESTION 8


8 The PMHNP understands that slow-dose extended release stimulants are most

appropriate forwhich patient with ADHD?


A. 8-year-old patient B. 24-year-old patient C. 55-year-old patient D. 82-year-old patient


QUESTION 9


A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should

the PMHNP include when discussing the side effects with the patient?


A. The formulation can have delayed actions when taken with food. B. Sedation can be a

common side effect of the drug. C. The medication can affect your blood pressure. D.

This drug does not cause any dependency.


QUESTION 10


The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will

thePMHNP include in the teaching?




pg. 3